Abstract
In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / blood supply
-
Adenocarcinoma / pathology
-
Angiopoietin-1
-
Angiopoietin-2
-
Animals
-
Apoptosis
-
Blood Vessels / pathology
-
Endothelial Growth Factors / genetics
-
Endothelial Growth Factors / physiology*
-
Endothelium, Vascular / pathology
-
Endothelium, Vascular / physiology
-
Glioblastoma / blood supply
-
Glioblastoma / pathology
-
Glioma / blood supply
-
Glioma / pathology
-
In Situ Hybridization
-
Lymphokines / genetics
-
Lymphokines / physiology*
-
Male
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / physiology*
-
Mice
-
Mice, Inbred C57BL
-
Muscle, Smooth, Vascular / pathology
-
Muscle, Smooth, Vascular / physiology
-
Neoplasm Transplantation
-
Neoplasms, Experimental / blood supply*
-
Neoplasms, Experimental / pathology*
-
Neovascularization, Pathologic*
-
Proteins / genetics
-
Proteins / physiology*
-
Rats
-
Rats, Sprague-Dawley
-
Up-Regulation
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Angiopoietin-1
-
Angiopoietin-2
-
Angpt1 protein, mouse
-
Angpt1 protein, rat
-
Endothelial Growth Factors
-
Lymphokines
-
Membrane Glycoproteins
-
Proteins
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors